← TrialMatch
HomeTrials

Evaluation of the Effect of Consensus-based Protocols for the Treatment of Minor Ailments

Minor ailments are common, self-limited conditions unrelated to the patient's underlying health problems or adverse effects of their current medications. Minor ailment services are pharmacist-led interventions that provide patients with the most appropriate recommendation when unsure about the medication for a specific

Condition(s)Community Pharmacy Services
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryMinor ailments are common, self-limited conditions unrelated to the patient's underlying health problems or adverse effects of their current medications. Minor ailment services are pharmacist-led interventions that provide patients with the most appropriate recommendation when unsure about the medication for a specific minor ailment. It involves advice on nonprescription drugs, non-pharmacological measures, or referral to another health care practitioner. In Colombia, evaluating and implementing this service could optimize nonprescription drugs use and improve minor ailment management in primary health care settings.
Who can participateInclusion Criteria: Drugstores and drugstores/pharmacies: * Establishments located in Medellin and Metropolitan area * Establishments that have a Pharmacy Technician serving as the technical director. * Establishments with electronic point-of-sale system for data collection. * Commitment to participate for the full 10-month study period. Participants (patients): * Explicit consent to participate in the study. * Are the direct consumers requesting the nonprescription drug (i.e., not requesting them on behalf of someone else). * Present one of the five predefined potential MA that will be included in the study: influenza-like syndrome and catarrh, headache, common cold, sore throat, and menstrual pain or cramps. * Have access to mobile phone for follow-upThe person requesting the OTC medicat
Ages18 Years to 65 Years
SexAll
Lead sponsorUniversidad de Antioquia
LocationsMedellĂ­n, Antioquia, Colombia
Start date2024-12-04
NCT IDNCT06378099
Official listinghttps://clinicaltrials.gov/study/NCT06378099

🔍 Search all trials →